The Hamilton Depression Rating Scale: has the gold standard become a lead weight?, The American Journal of Psychiatry, vol.161, issue.12, pp.2163-2177, 2004. ,
Bipolar disorder-focus on bipolar II disorder and mixed depression, The Lancet, vol.369, issue.9565, pp.935-945, 2007. ,
Network analysis: an integrative approach to the structure of psychopathology, Annual Review of Clinical Psychology, vol.9, pp.91-121, 2013. ,
, , 2015.
, The Network Structure of Symptoms of the Diagnostic and Statistical Manual of Mental Disorders, vol.10
Reporting of sample size calculation in randomised controlled trials: review. The BMJ, vol.338, 2009. ,
, J. R, 2018.
, Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis, Lancet, pp.32802-32809, 10128.
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multipletreatments meta-analysis, Lancet, issue.9665, pp.746-758, 2009. ,
, , pp.60046-60051
Bias, precision and statistical power of analysis of covariance in the analysis of randomized trials with baseline imbalance: a simulation study, BMC Medical Research Methodology, vol.14, p.49, 2014. ,
Antidepressant drug effects and depression severity: a patient-level meta-analysis, JAMA, vol.303, issue.1, pp.47-53, 2010. ,
, The initial field trials of DSM-5: new blooms and old thorns, vol.170, pp.1-5, 2013.
Depression is not a consistent syndrome: An investigation of unique symptom patterns in the STAR*D study, Journal of Affective Disorders, vol.172, pp.96-102, 2015. ,
, , 2016.
, Measuring Depression Over Time . . . or not? Lack of Unidimensionality and Longitudinal Measurement Invariance in Four Common Rating Scales of Depression, Psychological Assessment
Is placebo response in antidepressant trials rising or not? A reanalysis of datasets to conclude this long-lasting controversy, Evidence-Based Mental Health, vol.21, issue.1, pp.1-3, 2018. ,
, , 2008.
, The History and Current State of Antidepressant Clinical Trial Design: A Call to Action for Proofof-Concept Studies, The Journal of Clinical Psychiatry, vol.69, issue.10, pp.1513-1528
A rating scale for depression, Neurosurgery, and Psychiatry, vol.23, pp.56-62, 1960. ,
Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression, Molecular Psychiatry, vol.21, issue.4, pp.523-530, 2016. ,
Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials? Philosophy, Ethics, and Humanities in Medicine, vol.3, 2008. ,
Why Has the Antidepressant-Placebo Difference in Antidepressant Clinical Trials Diminished over the Past Three Decades?, CNS Neuroscience & Therapeutics, vol.16, issue.4, pp.217-226, 2010. ,
Research design features and patient characteristics associated with the outcome of antidepressant clinical trials, The American Journal of Psychiatry, vol.161, issue.11, pp.2045-2049, 2004. ,
The conundrum of depression clinical trials: one size does not fit all, International Clinical Psychopharmacology, vol.33, issue.5, pp.239-248, 2018. ,
The persistence of the placebo response in antidepressant clinical trials, Journal of Psychiatric Research, vol.42, issue.10, pp.791-796, 2008. ,
Relationship between depression severity entry criteria and antidepressant clinical trial outcomes, Biological Psychiatry, vol.62, issue.1, pp.65-71, 2007. ,
Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration, PLOS Med, vol.5, issue.2, 2008. ,
Association between antidepressant resistance in unipolar depression and subsequent bipolar disorder: cohort study, The British Journal of Psychiatry, vol.200, issue.1, pp.45-51, 2012. ,
Antidepressants: misnamed and misrepresented, World Psychiatry: Official Journal of the World Psychiatric Association (WPA), vol.14, issue.3, pp.302-303, 2015. ,
Empirically derived criteria cast doubt on the clinical significance of antidepressant-placebo differences, Contemporary Clinical Trials, vol.43, pp.60-62, 2015. ,
The Hamilton Depression Scale-accelerator or break on antidepressant drug discovery, Neurosurgery & Psychiatry, vol.85, issue.2, pp.119-120, 2014. ,
Presenting simulation results in a nested loop plot, BMC Medical Research Methodology, vol.14, p.129, 2014. ,
Sensitivity of the individual items of the Hamilton depression rating scale to response and its consequences for the assessment of efficacy, Journal of Psychiatric Research, vol.42, issue.12, pp.1000-1009, 2008. ,
From trial and error to trial simulation. Part 2: an appraisal of current beliefs in the design and analysis of clinical trials for antidepressant drugs, Clinical Pharmacology and Therapeutics, vol.86, issue.3, pp.255-262, 2009. ,
From Trial and Error to Trial Simulation. Part 1: The Importance of Model-Based Drug Development for Antidepressant Drugs, Clinical Pharmacology & Therapeutics, vol.86, issue.3, pp.248-254, 2009. ,
Reliability of the Hamilton Rating Scale for Depression: A meta-analysis over a period of 49 years, Psychiatry Research, vol.189, issue.1, pp.1-9, 2011. ,
Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy, New England Journal of Medicine, vol.358, issue.3, pp.252-260, 2008. ,
Evaluation of the results of a randomized controlled trial: how to define changes between baseline and follow-up, Journal of Clinical Epidemiology, vol.57, issue.3, pp.223-228, 2004. ,
The ClinicalTrials.gov Results Database -Update and Key Issues, The New England journal of medicine, vol.364, issue.9, pp.852-860, 2011. ,